Insider Transactions in Q2 2018 at Surface Oncology, Inc. (SURF)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 23
2018
|
Fil LTD |
BUY
Conversion of derivative security
|
Direct |
886,716
+50.0%
|
-
|
|
Apr 23
2018
|
Atlas Venture Fund Ix, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+2.11%
|
$1,500,000
$15.0 P/Share
|
|
Apr 23
2018
|
Atlas Venture Fund Ix, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,181,817
+41.18%
|
-
|
|
Apr 23
2018
|
Novartis Institutes For Bio Medical Research, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
766,666
+16.26%
|
$11,499,990
$15.0 P/Share
|
|
Apr 23
2018
|
Novartis Institutes For Bio Medical Research, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,181,816
+36.11%
|
-
|